Biotech

All Articles

Vertex, hammered by AATD again, falls 2 properties on throw out heap

.Tip's effort to alleviate an uncommon hereditary health condition has reached one more setback. The...

Vir increases 3 T-cell engagers from Sanofi, gives up 25% of team

.Vir Medical's second-quarter incomes file wasn't short of major headlines. The firm welcomed a trio...

Galapagos pauses CAR-T tissue therapy hearing over Parkinsonism scenario

.Galapagos has actually stopped briefly registration in a test of a BCMA-directed CAR-T cell therapy...

James Wilson leaving behind Penn to launch pair of brand-new biotechs

.After more than 30 years, genetics treatment innovator James Wilson M.D., Ph.D., is actually leavin...

3 biotechs make an effort to trump the summer season heat through dropping team

.As biotechs seek to switch a new webpage in August, at the very least 3 firms have shed team in tri...

venBio elevates $528M for 5th life scientific researches VC fund

.Veteran venture capital agency venBio has raised one more half a billion bucks to buy biotechs focu...

Otsuka pays $800M for Jnana and its own clinical-stage PKU drug

.Otsuka Pharmaceutical has picked up Boston-based Jnana Therapies for $800 million so the Japanese b...

FibroGen lays off 75% people team as resource flunks 2 additional trials

.FibroGen is actually substantially reorganizing its organization, laying off 75% of its USA team an...

Tracon relax full weeks after injectable PD-L1 prevention fail

.Tracon Pharmaceuticals has actually chosen to wane functions full weeks after an injectable immune ...

Ideaya bags option on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is wagering $400 thousand in biobucks that a bispecific antibody-drug conjugate ...